Purified anti-GM130, W18248A Antibody,BioLegend,937001

This clone does not recognize mouse GM130 by western blot.This clone was tested for ICC using HeLa cells fixed with 4% PFA and permeabilized with Triton X-100 or methanol. Both methods were compatible with GM130 staining.

Host

Rat

Reactivity

Human

Application

WB - Quality testedICC, IP - Verified

Platform ID

BAB019546229

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-GM130, W18248A Antibody
Cat. No.937001
HostRat
RRIDAB_2888895 (BioLegend Cat. No. 937001)AB_2888895 (BioLegend Cat. No. 937002)
IsotypeRat IgG2b, κ
ReactivityHuman
ApplicationWB - Quality testedICC, IP - Verified
ClonalityMonoclonal
Clone NumberW18248A
Concentration0.5 mg/mL
TargetGM130
ImmunogenPartial recombinant human GM130 protein
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

GM130 is a structural cis-Golgi protein that plays an essential role in vesicular transport. Mitotic fragmentation of the Golgi apparatus occurs through the CDK1-dependent regulation of the physical interaction between GM130 and the vesicle docking protein p115. Biochemical or genetic disruption of GM130 results in defective Golgi assembly. GM130 also plays a role in activating TPX2, a spindle assembly factor, to produce microtubule nuclei surrounding the Golgi, which are then directly bound by GM130 during mitotic events. Aberrant GM130 expression has been described in multiple malignancies where cells show altered Golgi structure and loss of polarity, lending to increased migration and invasion.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.